133 related articles for article (PubMed ID: 22765307)
1. Mutational analysis of PMP22, EGR2, LITAF and NEFL in Greek Charcot-Marie-Tooth type 1 patients.
Koutsis G; Pandraud A; Karadima G; Panas M; Reilly MM; Floroskufi P; Wood NW; Houlden H
Clin Genet; 2013 Apr; 83(4):388-91. PubMed ID: 22765307
[No Abstract] [Full Text] [Related]
2. Mutational analysis of GJB1, MPZ, PMP22, EGR2, and LITAF/SIMPLE in Serbian Charcot-Marie-Tooth patients.
Keckarevic-Markovic M; Milic-Rasic V; Mladenovic J; Dackovic J; Kecmanovic M; Keckarevic D; Savic-Pavicevic D; Romac S
J Peripher Nerv Syst; 2009 Jun; 14(2):125-36. PubMed ID: 19691535
[TBL] [Abstract][Full Text] [Related]
3. Mutation analysis of the PMP22, MPZ, EGR2, LITAF, and GJB1 genes in Korean patients with Charcot-Marie-Tooth neuropathy type 1.
Park HK; Kim BJ; Sung DH; Ki CS; Kim JW
Clin Genet; 2006 Sep; 70(3):253-6. PubMed ID: 16922730
[No Abstract] [Full Text] [Related]
4. Mutational analysis of PMP22, MPZ, GJB1, EGR2 and NEFL in Korean Charcot-Marie-Tooth neuropathy patients.
Choi BO; Lee MS; Shin SH; Hwang JH; Choi KG; Kim WK; Sunwoo IN; Kim NK; Chung KW
Hum Mutat; 2004 Aug; 24(2):185-6. PubMed ID: 15241803
[TBL] [Abstract][Full Text] [Related]
5. Molecular genetics of autosomal-dominant demyelinating Charcot-Marie-Tooth disease.
Houlden H; Reilly MM
Neuromolecular Med; 2006; 8(1-2):43-62. PubMed ID: 16775366
[TBL] [Abstract][Full Text] [Related]
6. Mutation frequency for Charcot-Marie-Tooth disease type 1 in the Chinese population is similar to that in the global ethnic patients.
Song S; Zhang Y; Chen B; Zhang Y; Wang M; Wang Y; Yan M; Zou J; Huang Y; Zhong N
Genet Med; 2006 Aug; 8(8):532-5. PubMed ID: 16912585
[TBL] [Abstract][Full Text] [Related]
7. Early onset neuropathy in a compound form of Charcot-Marie-Tooth disease.
Meggouh F; de Visser M; Arts WF; De Coo RI; van Schaik IN; Baas F
Ann Neurol; 2005 Apr; 57(4):589-91. PubMed ID: 15786462
[TBL] [Abstract][Full Text] [Related]
8. Pathomechanisms of mutant proteins in Charcot-Marie-Tooth disease.
Niemann A; Berger P; Suter U
Neuromolecular Med; 2006; 8(1-2):217-42. PubMed ID: 16775378
[TBL] [Abstract][Full Text] [Related]
9. Mutational analysis of PMP22, GJB1 and MPZ in Greek Charcot-Marie-Tooth type 1 neuropathy patients.
Karadima G; Floroskufi P; Koutsis G; Vassilopoulos D; Panas M
Clin Genet; 2011 Nov; 80(5):497-9. PubMed ID: 22243284
[No Abstract] [Full Text] [Related]
10. Tead1 regulates the expression of Peripheral Myelin Protein 22 during Schwann cell development.
Lopez-Anido C; Poitelon Y; Gopinath C; Moran JJ; Ma KH; Law WD; Antonellis A; Feltri ML; Svaren J
Hum Mol Genet; 2016 Jul; 25(14):3055-3069. PubMed ID: 27288457
[TBL] [Abstract][Full Text] [Related]
11. Clinical, electrophysiological and molecular genetic studies in a family with X-linked dominant Charcot-Marie-Tooth neuropathy presenting a novel mutation in GJB1 Promoter and a rare polymorphism in LITAF/SIMPLE.
Beauvais K; Furby A; Latour P
Neuromuscul Disord; 2006 Jan; 16(1):14-8. PubMed ID: 16373087
[TBL] [Abstract][Full Text] [Related]
12. Clinical and electrophysiological features in Charcot-Marie-Tooth disease with mutations in the NEFL gene.
Miltenberger-Miltenyi G; Janecke AR; Wanschitz JV; Timmerman V; Windpassinger C; Auer-Grumbach M; Löscher WN
Arch Neurol; 2007 Jul; 64(7):966-70. PubMed ID: 17620486
[TBL] [Abstract][Full Text] [Related]
13. The modifying effect a PMP22 deletion in a family with Charcot-Marie-Tooth type 1 neuropathy due to an EGR2 mutation.
Reményi V; Inczédy-Farkas G; Gál A; Bereznai B; Pál Z; Karcagi V; Mechler F; Molnár MJ
Ideggyogy Sz; 2014 Nov; 67(11-12):420-5. PubMed ID: 25720245
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic spectrum of Charcot-Marie-Tooth disease due to LITAF/SIMPLE mutations: a study of 18 patients.
Guimarães-Costa R; Iancu Ferfoglia R; Leonard-Louis S; Ziegler F; Magy L; Fournier E; Dubourg O; Bouche P; Maisonobe T; Lacour A; Moerman A; Latour P; Stojkovic T
Eur J Neurol; 2017 Mar; 24(3):530-538. PubMed ID: 28211240
[TBL] [Abstract][Full Text] [Related]
15. Inherited demyelinating neuropathies with micromutations of peripheral myelin protein 22 gene.
Taioli F; Cabrini I; Cavallaro T; Acler M; Fabrizi GM
Brain; 2011 Feb; 134(Pt 2):608-17. PubMed ID: 21252112
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic laboratory testing for Charcot Marie Tooth disease (CMT): the spectrum of gene defects in Norwegian patients with CMT and its implications for future genetic test strategies.
Østern R; Fagerheim T; Hjellnes H; Nygård B; Mellgren SI; Nilssen Ø
BMC Med Genet; 2013 Sep; 14():94. PubMed ID: 24053775
[TBL] [Abstract][Full Text] [Related]
17. Neurofilament light chain polypeptide gene mutations in Charcot-Marie-Tooth disease: nonsense mutation probably causes a recessive phenotype.
Abe A; Numakura C; Saito K; Koide H; Oka N; Honma A; Kishikawa Y; Hayasaka K
J Hum Genet; 2009 Feb; 54(2):94-7. PubMed ID: 19158810
[TBL] [Abstract][Full Text] [Related]
18. Squalenoyl siRNA PMP22 nanoparticles are effective in treating mouse models of Charcot-Marie-Tooth disease type 1 A.
Boutary S; Caillaud M; El Madani M; Vallat JM; Loisel-Duwattez J; Rouyer A; Richard L; Gracia C; Urbinati G; Desmaële D; Echaniz-Laguna A; Adams D; Couvreur P; Schumacher M; Massaad C; Massaad-Massade L
Commun Biol; 2021 Mar; 4(1):317. PubMed ID: 33750896
[TBL] [Abstract][Full Text] [Related]
19. Screening for mutations in a genetically heterogeneous disorder: DHPLC versus DNA sequence for mutation detection in multiple genes causing Charcot-Marie-Tooth neuropathy.
Takashima H; Boerkoel CF; Lupski JR
Genet Med; 2001; 3(5):335-42. PubMed ID: 11545686
[TBL] [Abstract][Full Text] [Related]
20. Genetic profile and onset features of 1005 patients with Charcot-Marie-Tooth disease in Japan.
Yoshimura A; Yuan JH; Hashiguchi A; Ando M; Higuchi Y; Nakamura T; Okamoto Y; Nakagawa M; Takashima H
J Neurol Neurosurg Psychiatry; 2019 Feb; 90(2):195-202. PubMed ID: 30257968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
